CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shan, W. L. P.
Right arrow Articles by Backman, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shan, W. L. P.
Right arrow Articles by Backman, S. B.
Canadian Journal of Anesthesia 51:1045-1046 (2004)
© Canadian Anesthesiologists' Society, 2004


Correspondence

Blood product use during orthotopic liver transplantation

W. Li Pi Shan, MD FRCPC, Jeffrey Barkun, MDCM, Peter Metrakos, MDCM PhD FRCSC, Jean Tchervenkov, MDCM FRCSC and Steven B. Backman, MDCM PhD FRCPC

Montreal, Quebec

To the Editor:

Although orthotopic liver transplantation (OLT) has traditionally been associated with transfusion of considerable quantities of blood products, this has been challenged recently.1–3 The present study evaluates blood product use during OLT at our hospital.

Following Ethics Board approval, data were analyzed from 218 consecutive first-time OLT (1995–2000). Anesthesia and surgery were performed using standard techniques.4 Venovenous bypass and the piggyback technique were never employed. All patients received aprotinin (500,000–2,000,000 U bolus followed by 500,000 U•hr–1). Intraoperative blood testing was minimized (1 mL samples for blood gas, hematocrit and electrolyte determination). Coagulation analysis (prothrombin time [PT], partial thromboplastin time [PTT], international normalized ratio [INR], fibrinogen level, platelet count) was done only if clinically indicated (excessive oozing, lack of clots). In the absence of neoplasm, scavenged blood was returned to the patient using a cell saver. Transfusion triggers for packed red blood cells (PRBC) included hematocrit less than 0.25 or sudden catastrophic blood loss. Platelets, cryoprecipitate, and fresh frozen plasma (FFP) were transfused on the clinical impression of "medical" bleeding. Predetermined transfusion triggers were not used. Patients were divided into Group I (no blood products used) and Group II (blood products used).

Of the 218 OLT, no blood products were given intraoperatively in 35 (16%) patients (Group I). Blood products were given to 183 patients in Group II (PRBC: 3.9 ± 2.8; FFP: 5.6 ± 4.1; platelets: 4.8 ± 7.6 and cryoprecipitate: 3.3 ± 5.6). Group I patients had a lower preoperative INR, PT, PTT, total bilirubin, ASA status, MELD score, Child-Pugh score, Canadian liver transplant status and they had a higher preoperative hemoglobin and albumin (TableGo). Groups I and II had a similar postoperative hematocrit (0.33 ± 0.04 and 0.31 ± 0.06, respectively), INR (2.3 ± 1.2 and 2.9 ± 2.5, respectively), PT (18.8 ± 5.2 and 20.6 ± 8.4, respectively), and PTT (74.9 ± 27.2 and 84.7 ± 36.1, respectively). However, Group 1 demonstrated a higher postoperative platelet count (124.8 ± 49.9 vs 92.8 ± 46.7, P < 0.0004). The only independent variable significantly associated with absence of any blood product transfusion was the Child-Pugh score (P = 0.019, odds ratio = 0.7, 95% confidence interval = 0.52–0.94). The MELD score (P = 0.087) and preoperative hemoglobin (P = 0.077) just failed to achieve statistical significance.


View this table:
[in this window]
[in a new window]
 
TABLE Comparison of preoperative variables in Group I (no products, n = 35) and Group II (n = 183)
 
The low requirement for use of blood products is consistent with recent reports.1–3 Possible factors include the skills of the transplant team, intraoperative acceptance of a lower hematocrit, and the correction of clinical bleeding rather than treatment of predetermined coagulation values.5 Other factors may include the use of aprotinin, avoidance of hypothermia and elevated central venous pressure, minimal blood sampling, and return of blood scavenged from the operative field.4 The degree of preoperative liver dysfunction was the only preoperative predictor of blood product transfusion.

References

1 Marcel RJ, Stegall WC, Suit CT, et al. Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation. Anesth Analg 1996; 82: 1122–5.[Abstract]

2 Cacciarelli TV, Keeffe EB, Moore DH, et al. Primary liver transplantation without transfusion of red blood cells. Surgery 1996; 120: 698–704.[Medline]

3 Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction requirements, and measures to reduce them. Liver Transpl 2003; 9: 1320–7.[Medline]

4 Baldry C, Backman SB, Metrakos, P, Tchervenkov J, Barkun J, Moore, A. Liver transplantation in a Jehovah’s Witness with ankylosing spondylitis. Can J Anesth 2000, 47: 642–6.[Abstract/Free Full Text]

5 Reyle-Hahn M, Rossaint R. Coagulation techniques are not important in directing blood product tansfusion during liver transplantation. Liver Transpl Surg 1997; 6: 659–63.




This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
T. Hennessey, K. Lachapelle, P. Ergina, P. Metrakos, and T. Schricker
44237 - TWO CASES OF HEART-LIVER TRANSPLANT ON CARDIOPULMONARY BYPASS
Can J Anesth, August 1, 2007; 54(suppl_1): 44237 - 44237.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shan, W. L. P.
Right arrow Articles by Backman, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shan, W. L. P.
Right arrow Articles by Backman, S. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS